Zymeworks (ZYME) PT Raised to $37 at Leerink Partners
Tweet
Share
E-mailGet Alerts ZYME Hot Sheet
Price: $25.12 --0%
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 12
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 12
Join SI Premium – FREE
Leerink Partners analyst Andrew Berens raised the price target on Zymeworks (NASDAQ: ZYME) to $37.00 (from $24.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, Andrew Berens, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
